| # | Drug | Count |
|---|---|---|
| 0 | VALACYCLOVIR | 12 |
| 1 | VALACYCLOVIR HYDROCHLORIDE | 12 |
| 2 | VENETOCLAX | 11 |
| 3 | CYCLOSPORINE | 10 |
| 4 | BUSULFAN | 8 |
| 5 | FLUDARABINE PHOSPHATE | 8 |
| 6 | ADALIMUMAB | 7 |
| 7 | ADALIMUMAB-AATY | 7 |
| 8 | ADALIMUMAB-ADAZ | 7 |
| 9 | ADALIMUMAB-FKJP | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GEMTUZUMAB OZOGAMICIN | 4 | 0.0011 |
| 1 | REVUMENIB | 1 | 0.0010 |
| 2 | DECITABINE | 4 | 0.0009 |
| 3 | BUSULFAN | 8 | 0.0005 |
| 4 | RIFAMPIN | 7 | 0.0005 |
| 5 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 1 | 0.0004 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 1 | 0.0004 |
| 7 | PENICILLIN V POTASSIUM | 1 | 0.0004 |
| 8 | ALEMTUZUMAB | 7 | 0.0004 |
| 9 | MOXIFLOXACIN HYDROCHLORIDE | 7 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Rifamycin Antibacterial [EPC] | 7 | 0.0002 |
| 4 | BCL-2 Inhibitor [EPC] | 11 | 0.0002 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 10 | 0.0001 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 9 | 0.0000 |
| 8 | Azole Antifungal [EPC] | 5 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 8 | 0.0000 |